18 Feb 2019
The National Rheumatoid Arthritis Society (NRAS) is sad to hear of the passing of veteran Labour MP, Paul Flynn. Paul had rheumatoid arthritis (RA) for many years and had been confined to his home over the last few months due to the disease.
9 Jan 2019
On 7th January 2019, the NHS Long Term Plan was released, which sets out objectives and strategies for the NHS in England over the next decade.
30 Oct 2018
See the following press release about an important new report on the state of play of osteoporosis in the UK.
15 Oct 2018
The first biosimilars to be introduced in rheumatology came to the UK market in early 2015, however, their use in rheumatoid arthritis is set to soar with the introduction of 4 biosimilars when Adalimumab comes off patent on 16th October, 2018.
24 Sep 2018
Biosimilar medicines represent very good value for the NHS since they are often much less costly than the originator medicine. Therefore the NHS is asking clinical teams, in discussion with individual patients, to ensure they are using the best value biological medicines – whether that is the originator biological medicine or a new biosimilar medicine – so that the money saved can be reinvested in new medicines and treatments for patients.